Biogen
BIIB
BIIB
1,058 hedge funds and large institutions have $36.3B invested in Biogen in 2020 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 339 increasing their positions, 437 reducing their positions, and 130 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% less first-time investments, than exits
New positions opened: 96 | Existing positions closed: 130
37% less call options, than puts
Call options by funds: $894M | Put options by funds: $1.43B
57% less funds holding in top 10
Funds holding in top 10: 49 → 21 (-28)
Holders
1,058
Holding in Top 10
21
Calls
$894M
Puts
$1.43B
Top Buyers
| 1 | +$204M | |
| 2 | +$170M | |
| 3 | +$159M | |
| 4 |
D.E. Shaw & Co
New York
|
+$128M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$102M |
Top Sellers
| 1 | -$925M | |
| 2 | -$434M | |
| 3 | -$409M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$314M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$221M |